Cargando…
Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer “cell therapy” clinics
BACKGROUND: The retinal pigment epithelium (RPE) is implicated in the pathophysiology of many retinal degenerative diseases. This cell layer is also an ideal target for cell-based therapies. Several early phase clinical trials evaluating cell therapy approaches for diseases involving the RPE, such a...
Autores principales: | Hinkle, John W., Mahmoudzadeh, Raziyeh, Kuriyan, Ajay E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504041/ https://www.ncbi.nlm.nih.gov/pubmed/34635174 http://dx.doi.org/10.1186/s13287-021-02546-9 |
Ejemplares similares
-
Schwann Cell-Mediated Preservation of Vision in Retinal Degenerative Diseases via the Reduction of Oxidative Stress: A Possible Mechanism
por: MAHMOUDZADEH, Raziyeh, et al.
Publicado: (2016) -
Factors Associated with Fluctuations in Central Subfield Thickness in Patients with Diabetic Macular Edema Using Diabetic Retinopathy Clinical Research Protocols T and V
por: Torjani, Ava, et al.
Publicado: (2022) -
Role of Schwann Cells in Preservation of Retinal Tissue Through Reduction of Oxidative Stress
por: Lashay, Alireza, et al.
Publicado: (2019) -
Unproven stem cell therapy for macular degeneration
por: Ansari, Zubair A., et al.
Publicado: (2017) -
Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges
por: Coco-Martin, Rosa M., et al.
Publicado: (2021)